Commentary

Podcast

Managed Care Cast Presents: Stakeholders Summit—Biosimilars in Inflammatory Diseases, Part 2

Author(s):

In part 2 of this 2-part podcast, a panel of experts discusses challenges with biosimilar uptake, interchangeability studies, patient and provider education.

Today we are bringing you part 2 of a 2-part sponsored podcast series discussing the use of biosimilars in inflammatory diseases. The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.

The conversation for today’s podcast includes challenges with biosimilar uptake, interchangeability studies, patient and provider education.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Eneline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA
CH LogoCenter for Biosimilars Logo